I-Arecoline hydrobromide CAS:300-08-3
Imiphumela yemithi ye-Arecoline hydrobromide ifaka phakathi ukuvuselela uhlelo lwezinzwa lwe-parasympathetic kanye nokuthuthukisa ukudluliselwa kwe-cholinergic neurotransmission. Nakuba isetshenziswa ngokomlando kwezokwelapha zendabuko ngenxa yemiphumela yayo yokuvuselela, ivame ukucwaningwa ngendima yayo ezifundweni ze-neuroscience ezihlobene nama-acetylcholine receptors kanye nezindlela zokubonisa izimpawu ze-neuronal. Ocwaningweni lwezokwelapha, i-arecoline hydrobromide isetshenziswa njengethuluzi lokucwaninga lokufunda umsebenzi we-acetylcholine receptor, ukujabula kwe-neuronal, kanye nezindlela zokukhulula i-neurotransmitter. Izakhiwo zayo ze-cholinergic ziyenza ibe usizo ekuchazeni ukusebenzisana okuyinkimbinkimbi ngaphakathi kohlelo lwezinzwa kanye nezinhloso zokwelapha ezingaba khona zezimo ze-neurological. Naphezu kokusebenza kwayo ocwaningweni, ukusetshenziswa kwayo emtholampilo kwe-arecoline hydrobromide kunqunyelwe ngenxa yemiphumela yayo emibi engaba khona, kufaka phakathi ukuphazamiseka kwesisu, i-diaphoresis, kanye nemiphumela yenhliziyo. Ngaphezu kwalokho, ukuhlangana kwayo nokuhlafuna i-betel nut kanye ne-carcinogenicity kuphakamisa ukukhathazeka mayelana nemiphumela yesikhathi eside yokuphepha kanye nempilo. Sekukonke, ngenkathi i-arecoline hydrobromide ibonisa ithemba ezindaweni zocwaningo zokufunda umsebenzi we-neuronal kanye nezindlela ze-cholinergic, ukusetshenziswa kwayo kwezokwelapha kunqunyelwe yizinto eziphathelene nokuphepha kanye nemiphumela emibi engaba khona. Uphenyo oluqhubekayo ngezakhiwo zalo zemithi lunganikeza ukuqonda ngezindlela zokwelapha ezintsha ezihlose izinhlelo ze-cholinergic kodwa kudinga ukuhlolwa ngokucophelela kwezingozi nezinzuzo zokusetshenziswa okungenzeka kokwelapha.
| Ukwakheka | C8H14BrNO2 |
| Ukuhlolwa | 99% |
| Ukubukeka | impuphu emhlophe |
| Inombolo ye-CAS | 300-08-3 |
| Ukupakisha | Encane futhi enkulu |
| Impilo Yeshelufu | iminyaka engu-2 |
| Isitoreji | Gcina endaweni epholile neyomile |
| Isitifiketi | I-ISO. |








